Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

Management of Olanzapine in Patients with New-Onset Diabetes

Assessment and Monitoring

  • Patients taking olanzapine require greater monitoring because of the increased risk of type 2 diabetes associated with this medication 3, 4
  • The American Diabetes Association recommends monitoring weight, glycemic control, and cholesterol levels regularly for patients on olanzapine 1, 2

Management Options

  • Consider switching to an antipsychotic with a more benign metabolic profile, such as aripiprazole or ziprasidone, which tend to have fewer metabolic effects 3, 5
  • If psychiatric symptoms are well-controlled, a complete switch to another antipsychotic may be appropriate, with a strength of evidence based on clinical guidelines 5
  • Initiate metformin as first-line therapy for addressing metabolic side effects, starting at 500 mg once daily and increasing to 1 g twice daily as tolerated, as recommended by the American Association of Clinical Endocrinologists 5

Monitoring Requirements

  • For patients who remain on olanzapine with diabetes, monitor weight, glycemic control, and cholesterol levels regularly, and incorporate monitoring of diabetes self-care activities into treatment goals 1, 2, 6
  • Screen for complications of diabetes, with a focus on early detection and prevention, as recommended by the American Diabetes Association 3

Clinical Pitfalls to Avoid

  • Avoid excessive anticholinergic burden, as olanzapine already has high anticholinergic activity, and be aware of the importance of coordinated care between psychiatric and medical providers 5, 1, 2